中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Menu
Volume 38 Issue 3
Mar.  2022
Turn off MathJax
Article Contents
Abstract
References
Article Navigation >  Journal of Clinical Hepatology  > 2022  >  38(3): 594-600

Risk factors for bile leakage after hepatectomy without biliary reconstruction: A Meta - analysis

DOI: 10.3969/j.issn.1001-5256.2022.03.019

  • Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chengdu Medical College, Chengdu 610500, China

More Information
  • Corresponding author: WU Qiang, wqsc111@163.com (ORCID: 0000-0001-7774-9720)
  • Received Date: 2021-07-16
  • Accepted Date: 2021-09-23
  • Published Date: 2022-03-20
    Abstract
  •   Objective  To investigate the risk factors for bile leakage after hepatectomy without biliary reconstruction.  Methods  CNKI, Wanfang Data, VIP, PubMed, Embase, Web of Science, and The Cochrane Library were searched for English and Chinese study reports on the risk factors for bile leakage after hepatectomy without biliary reconstruction published up to April 2021. The method of Cochrane systematic review was used for literature screening and data extraction, and Newcastle-Ottawa Scale was used for quality assessment. RevMan 5.4 software was used to perform a meta-analysis of the extracted data.  Results  A total of 16 articles (13 in English and 3 in Chinese) were included in this study, with a total of 16036 cases. The meta-analysis showed that sex (odds ratio [OR]=1.27, 95%CI: 1.09-1.48, P=0.003), diabetes (OR=1.23, 95%CI: 1.07-1.41, P=0.003), past history of liver surgery (OR=2.50, 95%CI: 1.74-3.59, P < 0.001), anatomic hepatectomy (OR=1.58, 95%CI: 1.09-2.30, P=0.02), segment I hepatectomy (OR=2.56, 95%CI: 1.50-4.40, P < 0.001), central hepatectomy (S4, S5, S8) (OR=3.51, 95%CI: 2.80-4.40, P < 0.001), left third hepatectomy (OR=3.53, 95%CI: 2.32-5.36, P < 0.001), and intraoperative blood transfusion (OR=2.64, 95%CI: 1.93-3.60, P < 0.001) were the risk factors for bile leakage after hepatectomy. Liver cirrhosis, preoperative liver function grade, preoperative chemotherapy, and left/right hemihepatectomy were not the risk factors for bile leakage.  Conclusion  There are complex influencing factors for bile leakage after hepatectomy, and in addition to the patient's own factors such as sex, diabetes, and past history of liver surgery, intraoperative factors, such as surgical procedures, extent of hepatectomy, and intraoperative blood transfusion, are also risk factors for bile leakage after hepatectomy. The surgeon should conduct adequate preoperative assessment and perform careful operation during surgery to reduce the incidence rate of postoperative bile leakage.

     

    • FullText(HTML)
    • References(46)
  • [1]
    CHEN X, LI K, WU YZ, et al. Multivariate analysis for risk factors of bile leakage after hepatectomy[J]. Chin J Gen Surg, 2013, 28(11): 850-853. DOI: 10.3760/cma.j.issn.1007-631X.2013.11.011.

    程翔, 李科, 吴雨哲, 等. 肝切除术后胆漏危险因素的多元回归分析[J]. 中华普通外科杂志, 2013, 28(11): 850-853. DOI: 10.3760/cma.j.issn.1007-631X.2013.11.011.
    [2]
    YAMASHITA YI, YAMAMOTO H, MIYATA H, et al. Risk factors for bile leakage: Latest analysis of 10 102 hepatectomies for hepatocellular carcinoma from the Japanese national clinical database[J]. J Hepatobiliary Pancreat Sci, 2021, 28(7): 556-562. DOI: 10.1002/jhbp.827.
    [3]
    MIURA F, YAMAMOTO M, GOTOH M, et al. Validation of the board certification system for expert surgeons (hepato-biliary-pancreatic field) using the data of the National Clinical Database of Japan: Part 1 - Hepatectomy of more than one segment[J]. J Hepatobiliary Pancreat Sci, 2016, 23(6): 313-323. DOI: 10.1002/jhbp.344.
    [4]
    YUE SQ. Diagnosis and treatment of biliary leakage after hepatectomy[J/CD]. Chin J Hepat Surg (Electronic Edition), 2013, 2(2): 128-130. DOI: 10.3877/cma.j.issn.2095-3232.2013.02.013.

    岳树强. 肝切除术后胆漏的诊断与治疗[J/CD]. 中华肝脏外科手术学电子杂志, 2013, 2(2): 128-130. DOI: 10.3877/cma.j.issn.2095-3232.2013.02.013.
    [5]
    WEN Y, MIAO XY, HUANG SF, et al. The prevention and treatment of bile leakage after the hepatectomy[J]. J Clin Surg, 2005, 13(10): 639-640. DOI: 10.3969/j.issn.1005-6483.2005.10.021.

    文宇, 苗雄鹰, 黄生福, 等. 肝切除术后胆漏的预防与处理[J]. 临床外科杂志, 2005, 13(10): 639-640. DOI: 10.3969/j.issn.1005-6483.2005.10.021.
    [6]
    GUO B, XU XL, HAN JW, et al. Research progress on the bile leakage after hepatectomy[J]. Hebei Med J, 2020, 42(23): 3639-3644. DOI: 10.3969/j.issn.1002-7386.2020.23.031.

    郭兵, 许晓磊, 韩军伟, 等. 肝切除术后胆漏研究进展[J]. 河北医药, 2020, 42(23): 3639-3644. DOI: 10.3969/j.issn.1002-7386.2020.23.031.
    [7]
    STANG A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses[J]. Eur J Epidemiol, 2010, 25(9): 603-605. DOI: 10.1007/s10654-010-9491-z.
    [8]
    SAKAMOTO K, TAMESA T, YUKIO T, et al. Risk factors and managements of bile leakage after hepatectomy[J]. World J Surg, 2016, 40(1): 182-189. DOI: 10.1007/s00268-015-3156-8.
    [9]
    SADAMORI H, YAGI T, SHINOURA S, et al. Risk factors for major morbidity after liver resection for hepatocellular carcinoma[J]. Br J Surg, 2013, 100(1): 122-129. DOI: 10.1002/bjs.8957.
    [10]
    PANARO F, HACINA L, BOUYABRINE H, et al. Risk factors for postoperative bile leakage: A retrospective single-center analysis of 411 hepatectomies[J]. Hepatobiliary Pancreat Dis Int, 2016, 15(1): 81-86. DOI: 10.1016/s1499-3872(15)60424-6.
    [11]
    NAKANO R, OHIRA M, KOBAYASHI T, et al. Independent risk factors that predict bile leakage after hepatectomy for hepatocellular carcinoma: Cohort study[J]. Int J Surg, 2018, 57: 1-7. DOI: 10.1016/j.ijsu.2018.07.005.
    [12]
    CAPUSSOTTI L, FERRERO A, VIGANÔ L, et al. Bile leakage and liver resection: Where is the risk?[J]. Arch Surg, 2006, 141(7): 690-694; discussion 695. DOI: 10.1001/archsurg.141.7.690.
    [13]
    DONADON M, COSTA G, CIMINO M, et al. Diagnosis and management of bile leaks after hepatectomy: Resultsof a prospective analysis of 475 hepatectomies[J]. World J Surg, 2016, 40(1): 172-181. DOI: 10.1007/s00268-015-3143-0.
    [14]
    ERDOGAN D, BUSCH OR, van DELDEN OM, et al. Incidence and management of bile leakage after partial liver resection[J]. Dig Surg, 2008, 25(1): 60-66. DOI: 10.1159/000118024.
    [15]
    GUILLAUD A, PERY C, CAMPILLO B, et al. Incidence and predictive factors of clinically relevant bile leakage in the modern era of liver resections[J]. HPB (Oxford), 2013, 15(3): 224-229. DOI: 10.1111/j.1477-2574.2012.00580.x.
    [16]
    HARIMOTO N, MURANUSHI R, HOSHINO K, et al. Albumin-Indocyanine Green Evaluation (ALICE) grade predicts bile leakage after hepatic resection[J]. Surg Today, 2020, 50(8): 849-854. DOI: 10.1007/s00595-020-01955-2.
    [17]
    SADAMORI H, YAGI T, MATSUDA H, et al. Risk factors for major morbidity after hepatectomy for hepatocellular carcinoma in 293 recent cases[J]. J Hepatobiliary Pancreat Sci, 2010, 17(5): 709-718. DOI: 10.1007/s00534-010-0275-3.
    [18]
    ISHⅡ H, OCHIAI T, MURAYAMA Y, et al. Risk factors and management of postoperative bile leakage after hepatectomy without bilioenteric anastomosis[J]. Dig Surg, 2011, 28(3): 198-204. DOI: 10.1159/000324042.
    [19]
    KAJIWARA T, MIDORIKAWA Y, YAMAZAKI S, et al. Clinical score to predict the risk of bile leakage after liver resection[J]. BMC Surg, 2016, 16(1): 30. DOI: 10.1186/s12893-016-0147-0.
    [20]
    LYU MF, GUO YM, WANG JG, et al. Analysis of risk factors for bile leakage after hepatectomy[J]. Hebei Med J, 2015, 37(16): 2442-2444. DOI: 10.3969/j.issn.1002-7386.2015.16.012.

    吕孟斐, 国义民, 王建国, 等. 肝切除术后胆漏的危险因素分析[J]. 河北医药, 2015, 37(16): 2442-2444. DOI: 10.3969/j.issn.1002-7386.2015.16.012.
    [21]
    DENG ZM, SUN Q. Risk factors and measures of prevention and treatment for bile leakage after hepatectomy[J]. Chin J Clin Res, 2016, 29(2): 204-206. DOI: 10.13429/j.cnki.cjcr.2016.02.015.

    邓仲鸣, 孙权. 肝切除术后并发胆漏危险因素及防治措施分析[J]. 中国临床研究, 2016, 29(2): 204-206. DOI: 10.13429/j.cnki.cjcr.2016.02.015.
    [22]
    ZHAI ZS. Multivariate regression analysis of risk factors for biliary leakage after hepatic R0 resection[J]. Chin Hepatol, 2015, 20(5): 404-407. DOI: 10.3969/j.issn.1008-1704.2015.05.017.

    翟中山. 肝R0切除术后发生胆漏危险因素的多元回归分析[J]. 肝脏, 2015, 20(5): 404-407. DOI: 10.3969/j.issn.1008-1704.2015.05.017.
    [23]
    KUBO N, SHIRABE K. Treatment strategy for isolated bile leakage after hepatectomy: Literature review[J]. Ann Gastroenterol Surg, 2020, 4(1): 47-55. DOI: 10.1002/ags3.12303.
    [24]
    LIU ZY, JIN H, LIU M, et al. Role of bile leakage test in preventing bile leakage during partial liver resection[J]. Chin J Gen Pract, 2014, 13(2): 139-141. DOI: 10.3760/cma.j.issn.1671-7368.2014.02.021.

    刘志毅, 金虎, 刘明, 等. 胆漏试验在肝部分切除术中预防胆漏的作用[J]. 中华全科医师杂志, 2014, 13(2): 139-141. DOI: 10.3760/cma.j.issn.1671-7368.2014.02.021.
    [25]
    LO CM, FAN ST, LIU CL, et al. Biliary complications after hepatic resection: Risk factors, management, and outcome[J]. Arch Surg, 1998, 133(2): 156-161. DOI: 10.1001/archsurg.133.2.156.
    [26]
    WU ZW. Analysis of related factors of bile leakage after hepatobiliary surgery[J]. Chin J Modern Operative Surg, 2014, 18(4): 260-262. DOI: 10.16260/j.cnki.1009-2188.2014.04.008.

    吴忠卫. 肝胆手术后胆漏的相关因素分析[J]. 中国现代手术学杂志, 2014, 18(4): 260-262. DOI: 10.16260/j.cnki.1009-2188.2014.04.008.
    [27]
    CHEN XP, PENG SY. Causes and treatment of bile leakage (a report of 22 cases)[J]. Chin J Pract Surg, 2001, 21(2): 102-104. DOI: 10.3321/j.issn:1005-2208.2001.02.020.

    陈晓鹏, 彭淑牖. 胆漏的原因及防治(附22例报告)[J]. 中国实用外科杂志, 2001, 21(2): 102-104. DOI: 10.3321/j.issn:1005-2208.2001.02.020.
    [28]
    ZHENG SM, LI H, LI GC, et al. Risk factors, treatment and impact on outcomes of bile leakage after hemihepatectomy[J]. ANZ J Surg, 2017, 87(7-8): e26-e31. DOI: 10.1111/ans.13073.
    [29]
    RAHBARI NN, ELBERS H, KOCH M, et al. Bilirubin level in the drainage fluid is an early and independent predictor of clinically relevant bile leakage after hepatic resection[J]. Surgery, 2012, 152(5): 821-831. DOI: 10.1016/j.surg.2012.03.012.
    [30]
    CHEN L, LI Y. The risk factors and prediction systems for posthepatectomy complications[J]. J Clin Hepatol, 2019, 35(1): 217-221. DOI: 10.3969/j.issn.1001-5256.2019.01.048.

    陈龙, 李钺. 肝切除术后并发症的危险因素及预测评分系统[J]. 临床肝胆病杂志, 2019, 35(1): 217-221. DOI: 10.3969/j.issn.1001-5256.2019.01.048.
    [31]
    YANG JM. Attention should be paid to surgical treatment of recurrent primary liver cancer[J]. J Clin Surg, 2005, 13(3): 129-130. DOI: 10.3969/j.issn.1005-6483.2005.03.001.

    杨甲梅. 重视复发性原发性肝癌的外科治疗[J]. 临床外科杂志, 2005, 13(3): 129-130. DOI: 10.3969/j.issn.1005-6483.2005.03.001.
    [32]
    BAGDADE JD, STEWART M, WALTERS E. Impaired granulocyte adherence. A reversible defect in host defense in patients with poorly controlled diabetes[J]. Diabetes, 1978, 27(6): 677-681. DOI: 10.2337/diab.27.6.677.
    [33]
    LI Q, WANG Y, MA T, et al. Clinical outcomes of patients with and without diabetes mellitus after hepatectomy: A systematic review and meta-analysis[J]. PLoS One, 2017, 12(2): e0171129. DOI: 10.1371/journal.pone.0171129.
    [34]
    INOUE Y, SUZUKI Y, YOKOHAMA K, et al. Diabetes mellitus does not influence results of hepatectomy in hepatocellular carcinoma: Case control study[J]. Contemp Oncol (Pozn), 2020, 24(4): 211-215. DOI: 10.5114/wo.2020.102825.
    [35]
    YAMAMOTO K, TAKADA Y, FUJIMOTO Y, et al. Nonalcoholic steatohepatitis in donors for living donor liver transplantation[J]. Transplantation, 2007, 83(3): 257-262. DOI: 10.1097/01.tp.0000250671.06456.3f.
    [36]
    FISCHER A, FUCHS J, STRAVODIMOS C, et al. Influence of diabetes on short-term outcome after major hepatectomy: An underestimated risk?[J]. BMC Surg, 2020, 20(1): 305. DOI: 10.1186/s12893-020-00971-w.
    [37]
    INOUE Y, SUZUKI Y, YOKOHAMA K, et al. Diabetes mellitus does not influence results of hepatectomy in hepatocellular carcinoma: Case control study[J]. Contemp Oncol (Pozn), 2020, 24(4): 211-215. DOI: 10.5114/wo.2020.102825.
    [38]
    LIANG J, ARⅡZUMI SI, NAKANO M, et al. Diabetes mellitus and/or nonalcoholic steatohepatitis-related hepatocellular carcinoma showed favorable surgical outcomes after hepatectomy[J]. Anticancer Res, 2019, 39(10): 5639-5643. DOI: 10.21873/anticanres.13760.
    [39]
    YAMASHITA Y, HAMATSU T, RIKIMARU T, et al. Bile leakage after hepatic resection[J]. Ann Surg, 2001, 233(1): 45-50. DOI: 10.1097/00000658-200101000-00008.
    [40]
    QIAO O, SUN ZW. Biliary leakage after hepatectomy[J]. J Hepatobiliary Surg, 2003, 11(2): 132-133. DOI: 10.3969/j.issn.1006-4761.2003.02.024.

    乔鸥, 孙志为. 肝切除术后胆漏[J]. 肝胆外科杂志, 2003, 11(2): 132-133. DOI: 10.3969/j.issn.1006-4761.2003.02.024.
    [41]
    NAGANO Y, TOGO S, TANAKA K, et al. Risk factors and management of bile leakage after hepatic resection[J]. World J Surg, 2003, 27(6): 695-698. DOI: 10.1007/s00268-003-6907-x.
    [42]
    FRVHLING P, HELLBERG K, EJDER P, et al. The prognostic value of C-reactive protein and albumin in patients undergoing resection of colorectal liver metastases. A retrospective cohort study[J]. HPB (Oxford), 2021, 23(6): 970-978. DOI: 10.1016/j.hpb.2020.10.019.
    [43]
    MA B, TANG GY, WANG L, et al. Prediction of independent risk factors for biliary leakage after hepatectomy for hepatocellular carcinoma[J]. Medical Diet and Health, 2018, 12: 72.

    马斌, 汤光耀, 王麟, 等. 预测肝细胞癌肝切除术后胆漏的独立危险因素[J]. 医学食疗与健康, 2018, 12: 72.
    [44]
    SPETZLER VN, SCHEPERS M, PINNSCHMIDT HO, et al. The incidence and severity of post-hepatectomy bile leaks is affected by surgical indications, preoperative chemotherapy, and surgical procedures[J]. Hepatobiliary Surg Nutr, 2019, 8(2): 101-110. DOI: 10.21037/hbsn.2019.02.06.
    [45]
    Chinese expert consensus and path management guideline for accelerated rehabilitation surgery (2018): Hepatobiliary surgery[J]. Chin J Anesthesiol, 2018, 38(1): 13-18. DOI: 10.3760/cma.j.issn.0254-1416.2018.01.101.

    加速康复外科中国专家共识暨路径管理指南(2018): 肝胆手术部分[J]. 中华麻醉学杂志, 2018, 38(1): 13-18. DOI: 10.3760/cma.j.issn.0254-1416.2018.01.101.
    [46]
    COSTA G, DONADON M, TORZILLI G. Post-hepatectomy biliary fistula: From risk factors to the role of drain placement and management-still a lot to be answered[J]. Hepatobiliary Surg Nutr, 2019, 8(4): 417-418. DOI: 10.21037/hbsn.2019.06.10.
    • Relative Articles

  • Relative Articles

    [1]Yunchong WU, Yanyan YANG, Chuan LI, Xiaohuan WU, Shide LIN. Role of inflammatory cytokines in disorder of glucose metabolism in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2024, 40(9): 1886-1890. doi: 10.12449/JCH240926
    [2]Zixiang GAO, Zhongliang SHEN, Jing LIU, Youhua XIE. Research advances in cytokines in the treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2022, 38(8): 1710-1715. doi: 10.3969/j.issn.1001-5256.2022.08.002
    [3]Huang ZhiQin, Huang HuiFang. Research advances in cytokines associated with primary biliary cholangitis[J]. Journal of Clinical Hepatology, 2020, 36(2): 446-450. doi: 10.3969/j.issn.1001-5256.2020.02.047
    [4]Zhang Yu, Shao YueMing, Qin TingTing, Yin Xin, Wen XiaoYu. Current research status and application value of cytokines in drug-induced liver injury[J]. Journal of Clinical Hepatology, 2020, 36(8): 1883-1886. doi: 10.3969/j.issn.1001-5256.2020.08.045
    [5]Wei XinHuan, Liu YaLi, Zhang Jing, Lin Wei. Expression and significance of cytokines in children with acute hepatitis A[J]. Journal of Clinical Hepatology, 2019, 35(9): 1942-1945. doi: 10.3969/j.issn.1001-5256.2019.09.011
    [6]Xiang Jiao, Jia XiaoDong, Lu ShanShan, Wu DaWei, Zhang Ting, Dong JinKe, Huang JiaGan, Li YinYin, Yang Bin, Xu Yong, Dong Zheng, Lu Ying, Zeng Zhen, Lu YinYing. Effect of cryoablation versus microwave ablation on clinical indices and cytokines in patients with hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2019, 35(8): 1728-1733. doi: 10.3969/j.issn.1001-5256.2019.08.016
    [7]Xu Ying, Zhang DingQi, Chen JiaMei, Liu Wei, Liu Ping. Effect of various cells on the activation of hepatic stellate cells in liver microenvironment[J]. Journal of Clinical Hepatology, 2019, 35(2): 424-430. doi: 10.3969/j.issn.1001-5256.2019.02.042
    [8]Liu Zhao, Ma WenTing, Zhang PengFei, Li JinKui, Xiao JianXi, Lei JunQiang. Research advances in molecular imaging of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2018, 34(4): 872-876. doi: 10.3969/j.issn.1001-5256.2018.04.038
    [9]Wu Han, Li ZhenLi, Xing Hao, Wang MingDa, Wu MengChao, Yang Tian. Research advances in the structure and function of osteopontin and its effect in diagnosis and treatment of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2018, 34(9): 1999-2003. doi: 10.3969/j.issn.1001-5256.2018.09.036
    [10]Huang YongJie, Wu DeQuan, Yuan JunHui. Current status of treatment of primary hepatocellular carcinoma in the elderly population[J]. Journal of Clinical Hepatology, 2018, 34(6): 1313-1317. doi: 10.3969/j.issn.1001-5256.2018.06.039
    [11]Sheng QingShou, Lai GuoQuan, Yu XueJing, Wei Cui. The role of traditional Chinese medicine in regulating cytokines associated with liver fibrosis[J]. Journal of Clinical Hepatology, 2018, 34(12): 2677-2680. doi: 10.3969/j.issn.1001-5256.2018.12.037
    [12]Zhang ZeYu, Cheng HongYan. Clinical application of positron emission tomography/computed tomography in hepatocellular carcinoma and related research advances[J]. Journal of Clinical Hepatology, 2017, 33(7): 1365-1368. doi: doi:10.3969/j.issn.1001-5256.2017.07.036
    [13]Chen WeiBo, Cai HuiHua, Yang Yue, Chen XueMin, Jiang Yong, Sun DongLin. Research advances in regorafenib in treatment of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2017, 33(12): 2425-2428. doi: 10.3969/j.issn.1001-5256.2017.12.039
    [14]Yang Liu, Zhu XiLing, Li Gong. Expression of programmed death-ligand 1 in hepatocellular carcinoma and its clinical significance[J]. Journal of Clinical Hepatology, 2016, 32(8): 1630-1634. doi: 10.3969/j.issn.1001-5256.2016.08.047
    [15]Zhang LiangJie, Chen HuiJuan, Zhao ShouSong. Effects of artificial liver plasma exchange on cytokines in patients with liver failure[J]. Journal of Clinical Hepatology, 2015, 31(4): 578-581. doi: 10.3969/j.issn.1001-5256.2015.04.024
    [16]Mao YiJia, Mao XiaoRong, Jiang Ni. Recent research on association between gene polymorphisms of IL-28B and other cytokines and HCV infection[J]. Journal of Clinical Hepatology, 2015, 31(8): 1347-1350. doi: 10.3969/j.issn.1001-5256.2015.08.044
    [17]Ma DeNing, Zhu XiaoDong, Tang ZhaoYou. Role of cancer- associated fibroblasts in growth and metastasis of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2014, 30(9): 865-868. doi: 10.3969/j.issn.1001-5256.2014.09.007
    [18]Zhang Ye, Zhang MingJie, Jia ZhanSheng. Research advances in cellular immunotherapy for primary hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2014, 30(9): 860-864. doi: 10.3969/j.issn.1001-5256.2014.09.006
    [19]Zhou Jian, Wan Hong. Relationship between changes in serum cytokine levels after artificial liver therapy and clinical prognosis in patients with liver failure[J]. Journal of Clinical Hepatology, 2013, 29(7): 535-537. doi: 1001-5256 (2013) 07-0535-03
    [20]Guan HaiTao, Zhao JinLi, Tang Rui, Sun LinLin. IL-17 promotes expression of fibrosis-related factors in hepatic stellate cells[J]. Journal of Clinical Hepatology, 2013, 29(5): 370-374.
    • Supplements(0)
    • Cited By

  • Cited by

    Periodical cited type(10)

    1. 李晏杰，王娜，王沙，唐鲲，毛德文，石清兰，龙富立. HBV相关性肝衰竭发病中的Th细胞免疫调控机制及中医药干预的研究进展. 内蒙古中医药. 2023(11): 134-138 .
    2. 霍瑞静，张翠丽，李静，何晨熙，李帅，高健. NF-κB信号通路对慢性乙型肝炎患者Th17/Treg相关细胞因子水平变化的影响. 中华医院感染学杂志. 2022(17): 2570-2573 .
    3. 黄杏，刘文志，陈斌. 清温并用法治疗肝衰竭的中医理论及作用机制探讨. 中国医学创新. 2021(10): 164-167 .
    4. 陈斌，丁秀丽，彭杰，黎运芳，王若宇，周意. 清温并用法对慢加急性肝衰竭肠源性内毒素血症大鼠结肠组织FoxP3, ROR-γt表达的影响. 中国实验方剂学杂志. 2020(02): 19-25 .
    5. 谭年花，陈斌，彭杰，朱文芳，张涛，周意，王若宇. 乙肝相关性慢加急性肝衰竭“阳黄-阴阳黄-阴黄”不同证候分型患者Treg/Th17的表达. 中国实验方剂学杂志. 2020(02): 33-38 .
    6. 陈斌，黎运芳，张涛，朱文芳，彭杰，张茜茜. 清温并用法对慢加急性肝衰竭大鼠肝组织Treg/Th17型细胞因子及转录因子的影响. 中华中医药杂志. 2020(09): 4618-4622 .
    7. 李薇，于佳卉，王新婷，王春梅，李贺，陈建光，孙靖辉. 北五味子总木脂素对环磷酰胺诱导的免疫功能低下小鼠的调节作用. 吉林大学学报(医学版). 2019(02): 294-299+472 .
    8. 陈斌，彭杰，张涛，朱文芳，张茜茜，丁秀丽，黎运芳. 清温并用法对慢加急性肝衰竭大鼠结肠组织调节性T淋巴细胞/辅助性T淋巴细胞17细胞因子的影响. 湖南中医药大学学报. 2019(05): 573-577 .
    9. 张龙跃，张序瑞. 赤芍解毒汤保留灌肠治疗慢加急性肝衰竭临床研究. 系统医学. 2019(13): 138-140 .
    10. 梁琼，赵隽，苏静，梁琳，张吉发. 凉血化瘀解毒法对急性肝衰竭模型大鼠免疫功能、Toll样受体及VEGF表达的影响. 中国中医急症. 2019(10): 1700-1704 .

    Other cited types(5)

  • Created with Highcharts 5.0.7Amount of accessChart context menuAbstract Views, HTML Views, PDF Downloads StatisticsAbstract ViewsHTML ViewsPDF Downloads2024-052024-062024-072024-082024-092024-102024-112024-122025-012025-022025-032025-04051015202530
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 4.6 %FULLTEXT: 4.6 %META: 91.8 %META: 91.8 %PDF: 3.5 %PDF: 3.5 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 5.2 %其他: 5.2 %其他: 1.1 %其他: 1.1 %China: 0.3 %China: 0.3 %India: 0.3 %India: 0.3 %Turkey: 0.8 %Turkey: 0.8 %[]: 1.1 %[]: 1.1 %上海: 3.8 %上海: 3.8 %北京: 9.8 %北京: 9.8 %南京: 0.5 %南京: 0.5 %南宁: 0.8 %南宁: 0.8 %吉林: 1.1 %吉林: 1.1 %宜宾: 0.5 %宜宾: 0.5 %张家口: 2.5 %张家口: 2.5 %杭州: 0.5 %杭州: 0.5 %济南: 0.3 %济南: 0.3 %石家庄: 0.5 %石家庄: 0.5 %福州: 0.3 %福州: 0.3 %美国伊利诺斯芝加哥: 0.3 %美国伊利诺斯芝加哥: 0.3 %芒廷维尤: 31.1 %芒廷维尤: 31.1 %莫斯科: 2.2 %莫斯科: 2.2 %西宁: 35.7 %西宁: 35.7 %长春: 1.1 %长春: 1.1 %长沙: 0.3 %长沙: 0.3 %其他其他ChinaIndiaTurkey[]上海北京南京南宁吉林宜宾张家口杭州济南石家庄福州美国伊利诺斯芝加哥芒廷维尤莫斯科西宁长春长沙

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(14)  / Tables(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (938) PDF downloads(55) Cited by(15)
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[2183]YesterdayPV[4802]TodayIP[506]TodayPV[867]Online[46]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return